Evigrade
ModerateLipid-modifying agents. Omega-3 polyunsaturated fatty acids×Vitamin K antagonist anticoagulants

Updated · Methodology

Mechanism

EPA displaces arachidonic acid in the platelet membrane and shifts synthesis towards thromboxane A3, far less aggregatory than A2. The effect on bleeding time is real but moderate and dose-dependent: it appears mainly above 3 g daily of EPA plus DHA, not with the usual 1 g capsule.

Symptoms

Bruises come slightly more easily and bleeding lasts longer after cuts or a dental extraction. At usual supplement doses most patients notice no change.

Management

There is no need to stop omega-3 routinely. Keep the dose steady, declare it to the prescriber and monitor INR as usual. If the regimen exceeds 3 g daily or antiplatelets are added, review the supplement dose before the anticoagulant's. Before planned surgery, discuss it with the surgical team.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Sources

Other interactions with Warfarin